Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05716958 · ClinicalTrials.gov registry record
Multi-Reader, Multi-Case, Cross-Over, Retrospective Study to Evaluate Effectiveness of Lunit INSIGHT DBT
A clinical trial of Breast Cancer, sponsored by Lunit.
- Completed
- Registry status
- 262
- Enrollment target
- 1
- Study location
NCT05716958: Completed study of Breast Cancer, sponsored by Lunit.
NCT05716958 is a study of Breast Cancer that has completed, run by Lunit. The registered enrollment target is 262 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05716958, a study of Breast Cancer, has completed, sponsored by Lunit.
- COMPLETED
- Registry status
- 262 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate Effectiveness of Lunit INSIGHT DBT in the assistance of detection and diagnosis of breast cancer during 3D mammography interpretation
Conditions Studied
Interventions
- RADIATION Digital Breast Tomosynthesis
Study Locations (1)
Maryland
- Anne Arundel Medical Center - Annapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2022-03-22 |
| Est. Completion | 2023-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05716958
The ClinicalTrials.gov registry entry for NCT05716958 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 262 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (91% lower). The listed sponsor is Lunit, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Digital Breast Tomosynthesis is the first listed.
NCT05716958 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT05716958 about?
NCT05716958 is a clinical study titled "Multi-Reader, Multi-Case, Cross-Over, Retrospective Study to Evaluate Effectiveness of Lunit INSIGHT DBT". This study aims to evaluate Effectiveness of Lunit INSIGHT DBT in the assistance of detection and diagnosis of breast cancer during 3D mammography interpretation
What is the current status of trial NCT05716958?
This trial is currently completed. The enrollment target is 262 participants. The study started on 2022-03-22. Estimated completion is 2023-02-28.
What conditions does trial NCT05716958 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT05716958?
The interventions under investigation include: Digital Breast Tomosynthesis (RADIATION).
Who is sponsoring clinical trial NCT05716958?
This trial is sponsored by Lunit, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05716958 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.